188 related articles for article (PubMed ID: 31299857)
1. PACAP27 induces migraine-like attacks in migraine patients.
Ghanizada H; Al-Karagholi MA; Arngrim N; Olesen J; Ashina M
Cephalalgia; 2020 Jan; 40(1):57-67. PubMed ID: 31299857
[TBL] [Abstract][Full Text] [Related]
2. PACAP38 dose-response pilot study in migraine patients.
Vollesen AL; Guo S; Ashina M
Cephalalgia; 2017 Apr; 37(4):391-395. PubMed ID: 27084887
[TBL] [Abstract][Full Text] [Related]
3. PACAP38 induces migraine-like attacks in patients with migraine without aura.
Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M
Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139
[TBL] [Abstract][Full Text] [Related]
4. Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study.
Ghanizada H; Al-Karagholi MA; Arngrim N; Ghanizada M; Larsson HBW; Amin FM; Ashina M
Peptides; 2019 Nov; 121():170134. PubMed ID: 31449829
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.
Amin FM; Hougaard A; Schytz HW; Asghar MS; Lundholm E; Parvaiz AI; de Koning PJ; Andersen MR; Larsson HB; Fahrenkrug J; Olesen J; Ashina M
Brain; 2014 Mar; 137(Pt 3):779-94. PubMed ID: 24501094
[TBL] [Abstract][Full Text] [Related]
6. Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
Guo S; Vollesen AL; Hansen YB; Frandsen E; Andersen MR; Amin FM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):136-147. PubMed ID: 26994298
[TBL] [Abstract][Full Text] [Related]
7. Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine.
Guo S; Vollesen AL; Hansen RD; Esserlind AL; Amin FM; Christensen AF; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):125-135. PubMed ID: 26994299
[TBL] [Abstract][Full Text] [Related]
8. The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache.
Vollesen ALH; Snoer A; Chaudhry B; Petersen AS; Hagedorn A; Hoffmann J; Jensen RH; Ashina M
Cephalalgia; 2020 Nov; 40(13):1474-1488. PubMed ID: 32962406
[TBL] [Abstract][Full Text] [Related]
9. Effect of the H
Vollesen LH; Guo S; Andersen MR; Ashina M
Cephalalgia; 2019 Apr; 39(5):597-607. PubMed ID: 30165750
[TBL] [Abstract][Full Text] [Related]
10. Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial.
Wienholtz NKF; Christensen CE; Zhang DG; Coskun H; Ghanizada H; Al-Karagholi MA; Hannibal J; Egeberg A; Thyssen JP; Ashina M
Cephalalgia; 2021 May; 41(6):731-748. PubMed ID: 33567890
[TBL] [Abstract][Full Text] [Related]
11. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.
Pellesi L; Al-Karagholi MA; De Icco R; Coskun H; Elbahi FA; Lopez-Lopez C; Snellman J; Hannibal J; Amin FM; Ashina M
JAMA Netw Open; 2021 Aug; 4(8):e2118543. PubMed ID: 34357396
[TBL] [Abstract][Full Text] [Related]
12. Investigation of carbachol and PACAP38 in a human model of migraine.
Schytz HW
Dan Med Bull; 2010 Dec; 57(12):B4223. PubMed ID: 21122466
[TBL] [Abstract][Full Text] [Related]
13. The role of genetics on migraine induction triggered by CGRP and PACAP38.
Guo S
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
[TBL] [Abstract][Full Text] [Related]
14. Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.
Ghanizada H; Al-Karagholi MA; Arngrim N; Mørch-Rasmussen M; Metcalf-Clausen M; Larsson HBW; Amin FM; Ashina M
J Headache Pain; 2020 Feb; 21(1):19. PubMed ID: 32093617
[TBL] [Abstract][Full Text] [Related]
15. Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine: A Randomized Crossover Study.
Ghanizada H; Al-Karagholi MA; Arngrim N; Mørch-Rasmussen M; Walker CS; Hay DL; Ashina M
Neurology; 2021 May; 96(20):e2488-e2499. PubMed ID: 33827963
[TBL] [Abstract][Full Text] [Related]
16. Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers.
Pellesi L; Al-Karagholi MA; Chaudhry BA; Lopez CL; Snellman J; Hannibal J; Amin FM; Ashina M
Cephalalgia; 2020 Oct; 40(11):1212-1223. PubMed ID: 32594760
[TBL] [Abstract][Full Text] [Related]
17. The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study.
Rasmussen NB; Deligianni C; Christensen CE; Karlsson WK; Al-Khazali HM; Van de Casteele T; Granhall C; Amin FM; Ashina M
J Headache Pain; 2023 May; 24(1):60. PubMed ID: 37231350
[TBL] [Abstract][Full Text] [Related]
18. Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs.
Naruse S; Suzuki T; Ozaki T; Nokihara K
Peptides; 1993; 14(3):505-10. PubMed ID: 8101368
[TBL] [Abstract][Full Text] [Related]
19. PACAP38 in human models of primary headaches.
Ashina H; Guo S; Vollesen ALH; Ashina M
J Headache Pain; 2017 Nov; 18(1):110. PubMed ID: 29453754
[TBL] [Abstract][Full Text] [Related]
20. Change in brain network connectivity during PACAP38-induced migraine attacks: A resting-state functional MRI study.
Amin FM; Hougaard A; Magon S; Asghar MS; Ahmad NN; Rostrup E; Sprenger T; Ashina M
Neurology; 2016 Jan; 86(2):180-7. PubMed ID: 26674334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
